These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8725761)

  • 1. Comparison of magnetic resonance imaging and transvaginal ultrasonography with hysterosalpingography in the evaluation of women exposed to diethylstilbestrol.
    Kipersztok S; Javitt M; Hill MC; Stillman RJ
    J Reprod Med; 1996 May; 41(5):347-51. PubMed ID: 8725761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uterine anomalies in diethylstilbestrol-exposed women with fertility disorders.
    Ben-Baruch G; Menczer J; Mashiach S; Serr DM
    Acta Obstet Gynecol Scand; 1981; 60(4):395-7. PubMed ID: 7282306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormalities of the uterus and cervix after diethylstilbestrol exposure: correlation of findings on MR and hysterosalpingography.
    van Gils AP; Tham RT; Falke TH; Peters AA
    AJR Am J Roentgenol; 1989 Dec; 153(6):1235-8. PubMed ID: 2816640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-shaped uterus in diethylstilbestrol (DES) exposure.
    Rennell CL
    AJR Am J Roentgenol; 1979 Jun; 132(6):979-80. PubMed ID: 108980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural changes of the genital tract associated with in utero exposure to diethylstilbestrol.
    Kaufman RH
    Obstet Gynecol Annu; 1982; 11():187-202. PubMed ID: 7110645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upper reproductive tract radiographic findings in DES-exposed female offspring.
    Nunley WC; Pope TL; Bateman BG
    AJR Am J Roentgenol; 1984 Feb; 142(2):337-9. PubMed ID: 6607604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of three dimensional transvaginal ultrasonography and hysterosalpingography in diagnosing uterine anomalies.
    Szkodziak P; Woźniak S; Czuczwar P; Paszkowski T; Milart P; Wozniakowska E; Szlichtyng W
    Ginekol Pol; 2014 May; 85(5):354-9. PubMed ID: 25011216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic differences in upper genital tract abnormalities and reproductive history in dizygotic twins exposed to diethylstilbestrol in utero. A case report.
    Claman P; Berger MJ
    J Reprod Med; 1990 Apr; 35(4):431-3. PubMed ID: 2352239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transvaginal ultrasound studies of vascular and morphological changes in uteri exposed to diethylstilbestrol in utero.
    Salle B; Sergeant P; Awada A; Bied-Damon V; Gaucherand P; Boisson C; Guibaud S; Benchaib M; Rudigoz RC
    Hum Reprod; 1996 Nov; 11(11):2531-6. PubMed ID: 8981149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upper genital tract changes associated with exposure in utero to diethylstilbestrol.
    Kaufman RH; Binder GL; Gray PM; Adam E
    Am J Obstet Gynecol; 1977 May; 128(1):51-9. PubMed ID: 851159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infertility in women exposed to diethylstilbestrol in utero.
    Haney AF; Hammond MG
    J Reprod Med; 1983 Dec; 28(12):851-6. PubMed ID: 6663585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Uterus and diethylstilbestrol: which examinations, which antecedents for an active management? Which treatments?].
    Aubriot FX; Chapron C; Dubuisson JB; Hamou JE
    Contracept Fertil Sex; 1998; 26(7-8):598-604. PubMed ID: 9810140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diethylstilbestrol-induced upper genital tract abnormalities.
    Haney AF; Hammond CB; Soules MR; Creasman WT
    Fertil Steril; 1979 Feb; 31(2):142-6. PubMed ID: 761676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrauterine exposure to diethylstilbestrol: long-term effects in humans.
    Swan SH
    APMIS; 2000 Dec; 108(12):793-804. PubMed ID: 11252812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fertility disorders attributable to the use of diethylstilbestrol during intrauterine life].
    Drapier E
    Rev Fr Gynecol Obstet; 1984 Apr; 79(4):297-300, 303-5. PubMed ID: 6397835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preeclampsia risk in women exposed in utero to diethylstilbestrol.
    Troisi R; Titus-Ernstoff L; Hyer M; Hatch EE; Robboy SJ; Strohsnitter W; Palmer JR; Øglaend B; Adam E; Kaufman R; Herbst AL; Hoover RN
    Obstet Gynecol; 2007 Jul; 110(1):113-20. PubMed ID: 17601905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hysteroscopic metroplasty for uterine enlargement: a treatment for diethylbestrol-exposed and hypoplastic uteri].
    Garbin O; Dellenbach P
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(1):41-6. PubMed ID: 8901300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upper genital tract changes and infertility in diethylstilbestrol-exposed women.
    Kaufman RH; Adam E; Noller K; Irwin JF; Gray M
    Am J Obstet Gynecol; 1986 Jun; 154(6):1312-8. PubMed ID: 3717241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are implantation and pregnancy outcome impaired in diethylstilbestrol-exposed women after in vitro fertilization and embryo transfer?
    Karande VC; Lester RG; Muasher SJ; Jones DL; Acosta AA; Jones HW
    Fertil Steril; 1990 Aug; 54(2):287-91. PubMed ID: 2379627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DES daughters in France: experts' points of view on the various genital, uterine and obstetric pathologies, and in utero DES exposure.
    Clement R; Guilbaud E; Barrios L; Rougé-Maillart C; Jousset N; Rodat O
    Med Sci Law; 2014 Oct; 54(4):219-29. PubMed ID: 24534146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.